<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intravenous anesthetic drug dosing for obese patients&lt;sup&gt;[1-20]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intravenous anesthetic drug dosing for obese patients<sup>[1-20]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Intravenous anesthetic drug dosing for obese patients<sup>[1-20]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="20%"></colgroup><colgroup width="60%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Weight for dosing</td> <td class="subtitle1">Notes</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Sedative/hypnotics</td> </tr> <tr> <td class="indent1">Propofol bolus doses</td> <td class="centered">AdjBW</td> <td> </td> </tr> <tr> <td class="indent1">Propofol maintenance infusions</td> <td class="centered">AdjBW</td> <td>Titrate to clinical endpoint.</td> </tr> <tr> <td class="indent1">Etomidate</td> <td class="centered">AdjBW</td> <td> </td> </tr> <tr> <td class="indent1">Ketamine</td> <td class="centered">AdjBW</td> <td> </td> </tr> <tr> <td class="indent1">Thiopental</td> <td class="centered">AdjBW</td> <td>Doses should be adjusted for high or low cardiac output, and rapid redistribution may result in more rapid awakening after a single bolus dose than in lean patients.</td> </tr> <tr> <td class="indent1">Midazolam (and other benzodiazepines) bolus doses</td> <td class="centered">TBW</td> <td>For sedation, usually dosed in small increments (eg, midazolam 1 mg IV) titrated to effect. Caution should be exercised as patients with OSA may have increased central sensitivity to the sedative and respiratory effects of benzodiazepines. TBW is used for induction of anesthesia, due to high lipophilicity and thus increased volume of distribution in obese patients.</td> </tr> <tr> <td class="indent1">Midazolam (and other benzodiazepines) continuous infusions</td> <td class="centered">AdjBW</td> <td>Titrate to effect.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Dexmedetomidine</td> <td class="centered">TBW</td> <td>Titrate to effect. Dose adjustments may be required for comorbidities or other sedative or anesthetic drugs used concomitantly.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Opioids</td> </tr> <tr> <td class="indent1">Synthetic opioids (fentanyl, sufentanil, alfentanil, and remifentanil)</td> <td class="centered">TBW</td> <td>When possible, titrate to effect.</td> </tr> <tr> <td class="indent1">Morphine</td> <td class="centered">IBW</td> <td>Initial dosing should be based on IBW and further administration titrated to effect.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Hydromorphone</td> <td class="centered">IBW</td> <td>As with morphine, initial dosing is based on IBW and then further titrated to effect.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Lidocaine, systemic</td> </tr> <tr> <td class="indent1">Bolus</td> <td class="centered">AdjBW</td> <td> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Infusion</td> <td class="centered">AdjBW</td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Neuromuscular blocking agents</td> </tr> <tr> <td class="indent1">Nondepolarizing agents (eg, vecuronium, rocuronium)</td> <td class="centered">IBW versus TBW</td> <td>The dosing scalar will depend on the clinical circumstance. In general, a higher (ie, closer to TBW) intubating dose will result in faster onset and shorter time to complete NMB, but a longer duration of action. An IBW-based dosing will prolong the time to ideal intubating conditions, but assure a faster recovery from NMB.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Succinylcholine</td> <td class="centered">TBW</td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Reversal agents</td> </tr> <tr> <td class="indent1">Sugammadex</td> <td class="centered">AdjBW</td> <td> </td> </tr> <tr> <td class="indent1">Neostigmine</td> <td class="centered">AdjBW</td> <td> </td> </tr> </tbody></table></div><div class="graphic_lgnd">The optimal method for calculating weight based doses of many medications in obese patients is unclear, with limited available literature. When possible and appropriate, anesthetic medications should be titrated to effect with incremental doses or incrementally adjusted infusions. The dosing strategy in this table is based on available pharmacokinetic and pharmacodynamic data in obesity, such data in non-obese patients, clinical experience, and the clinical use of the drug.</div><div class="graphic_footnotes">AdjBW: adjusted body weight; TBW: total body weight; IV: intravenous; OSA: obstructive sleep apnea; IBW: ideal body weight; NMB: neuromuscular blockade.</div><div class="graphic_reference">References:

<ol>
<li>Wada DR, Björkman S, Ebling WF, et al. Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology 1997; 87:884.</li>
<li>Ingrande J, Brodsky JB, Lemmens HJ. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg 2011; 113:57.</li>
<li>Echevarria GC, Elgueta MF, Donosoto MT, et al. The effective effect-site propofol concentration for induction and intubation with two pharmacokinetic models in morbidly obese patients using total body weight. Anesth Analg 2012; 115:823.</li>
<li>Greenblatt DJ, Abernethy DR, Locniskar A, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984; 61:27.</li>
<li>Feld J, Hoffman WE. Response entropy is more reactive than bispectral index during laparoscopic gastric banding. J Clin Monit Comput 2006; 20:229.</li>
<li>Bakhamees HS, El-Halafawy YM, El-Kerdawy HM, et al. Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East J Anesthesiol 2007; 19:537.</li>
<li>Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg 2008; 106:1741.</li>
<li>Ramsay MA. Bariatric surgery: The role of dexmedetomidine. Seminars in Anesthesia, Perioperative Medicine and Pain 2006; 25:51.</li>
<li>Leykin Y, Pellis T, Lucca M, et al. The effects of cisatracurium on morbidly obese women. Anesth Analg 2004; 99:1090.</li>
<li>Lemmens HJ, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth Analg 2006; 102:438.</li>
<li>Abernethy DR, Greenblatt DJ. Lidocaine disposition in obesity. Am J Cardiol 1984; 53:1183.</li>
<li>Schwartz AE, Matteo RS, Ornstein E, et al. Pharmacokinetics of sufentanil in obese patients. Anesth Analg 1991; 73:790.</li>
<li>Scholz J, Steinfath M, Schulz M. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. Clin Pharmacokinet 1996; 31:275.</li>
<li>Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89:562.</li>
<li>Schwartz AE, Matteo RS, Ornstein E, et al. Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth Analg 1992; 74:515.</li>
<li>Pühringer FK, Keller C, Kleinsasser A, et al. Pharmacokinetics of rocuronium bromide in obese female patients. Eur J Anaesthesiol 1999; 16:507.</li>
<li>Rose JB, Theroux MC, Katz MS. The potency of succinylcholine in obese adolescents. Anesth Analg 2000; 90:576.</li>
<li>Jung D, Mayersohn M, Perrier D, et al. Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology 1982; 56:269.</li>
<li>De Oliveira GS Jr, Duncan K, Fitzgeral P, et al. Systemic Lidocaine to Improve Quality of Recovery after Laparoscopic Bariatric Surgery: A Randomized Double-Blinded Placebo-Controlled Trial. Obes Surg 2014; 24:212.</li>
<li>Carabalona JF, Delwarde B, Duclos A, et al. Serum Concentrations of Lidocaine During Bariatric Surgery. Anesth Analg 2020; 130:e5.</li>
</ol></div><div id="graphicVersion">Graphic 90705 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
